232 related articles for article (PubMed ID: 21256579)
1. Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.
Weinberg LE; Lurain JR; Singh DK; Schink JC
Gynecol Oncol; 2011 May; 121(2):285-9. PubMed ID: 21256579
[TBL] [Abstract][Full Text] [Related]
2. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy.
Yoo SC; Kim WY; Yoon JH; Chang SJ; Chang KH; Ryu HS
Acta Obstet Gynecol Scand; 2010; 89(1):126-30. PubMed ID: 19878051
[TBL] [Abstract][Full Text] [Related]
3. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
Low JJ; Perrin LC; Crandon AJ; Hacker NF
Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the effect of fertility-saving surgery on young patients with malignant ovarian tumors].
Xi MR; Hou MM; Cao ZY; Zhang CS; Peng ZL; Wang HJ; Zheng A
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):233-6. PubMed ID: 16759456
[TBL] [Abstract][Full Text] [Related]
5. Malignant ovarian germ cell tumors: a single-institution experience.
Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162
[TBL] [Abstract][Full Text] [Related]
7. Conservative treatment of ovarian cancer. Safety, ovarian function preservation, reproductive ability, and emotional attitude of the patients in Saudi Arabia.
Sait KH
Saudi Med J; 2011 Sep; 32(9):913-8. PubMed ID: 21894353
[TBL] [Abstract][Full Text] [Related]
8. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract][Full Text] [Related]
9. Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.
Gadducci A; Lanfredini N; Tana R
Gynecol Endocrinol; 2014 Jul; 30(7):467-71. PubMed ID: 24702194
[TBL] [Abstract][Full Text] [Related]
10. Reproductive function after treatment of ovarian germ cell malignancy.
Anita AN; Rushdan MN
Med J Malaysia; 2012 Feb; 67(1):71-6. PubMed ID: 22582552
[TBL] [Abstract][Full Text] [Related]
11. [Adjuvant therapy of malignant ovarian tumors after organ preserving surgery].
Schröder W
Zentralbl Gynakol; 1996; 118(10):565-70. PubMed ID: 8912476
[TBL] [Abstract][Full Text] [Related]
12. A successful IVF-pregnancy in a patient who underwent conservative surgery followed by a regimen of cisplatin, vinblastine and peplomycin to treat an advanced ovarian mixed germ cell tumour: a case report.
Kitajima Y; Endo T; Hayashi T; Ishioka S; Baba T; Honnma H; Saito T
Hum Reprod; 2007 Mar; 22(3):850-2. PubMed ID: 17067995
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors.
Zhang N; Chen R; Hua K; Zhang Y
J Ovarian Res; 2017 Jul; 10(1):52. PubMed ID: 28750644
[TBL] [Abstract][Full Text] [Related]
14. [Malignant ovarian germ cell tumours: a trial of 36 cases].
Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
[TBL] [Abstract][Full Text] [Related]
15. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of ovarian germ cell tumors.
Williams SD
Hematol Oncol Clin North Am; 1991 Dec; 5(6):1261-9. PubMed ID: 1663943
[TBL] [Abstract][Full Text] [Related]
17. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas.
Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A
Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601
[TBL] [Abstract][Full Text] [Related]
19. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
20. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
